HA
BEAM icon

HHLR Advisors’s Beam Therapeutics BEAM Stock Holding History

HHLR Advisors’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,448,161
Closed -$126M – 79
2021
Q3 		$126M Sell
1,448,161
-397,592
-22% -$39.9M 1.65% 12
2021
Q2 		$238M Sell
1,845,753
-226,926
-11% -$18.1M 2.45% 14
2021
Q1 		$166M Sell
2,072,679
-893,724
-30% -$85M 1.64% 16
2020
Q4 		$242M Hold
2,966,403
– – 1.93% 15
2020
Q3 		$73M Hold
2,966,403
– – 0.55% 26
2020
Q2 		$83.1M Hold
2,966,403
– – 0.76% 25
2020
Q1 		$53.4M Buy
+2,966,403
New +$64.5M 0.72% 25

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

HHLR Advisors's BEAM Position: Q4 2021 in Review

HHLR Advisors sold out of Beam Therapeutics (BEAM) in Q4 2021, closing a stake of 1,448,161 shares — an estimated $126M sold.

HHLR Advisors first reported a position in BEAM in Q1 2020 and held it in 7 quarters. The position peaked at $242M in Q4 2020. 232 funds tracked by Wall St. Rank hold BEAM as of Q4 2021.

  • HHLR Advisors reported no remaining Beam Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HHLR Advisors sold 1,448,161 Beam Therapeutics shares in Q4 2021, an estimated $126M.
  • HHLR Advisors first reported a position in Beam Therapeutics in Q1 2020 and held it in 7 quarters.
  • HHLR Advisors's Beam Therapeutics position peaked at $242M in Q4 2020.
  • 232 funds tracked by Wall St. Rank held Beam Therapeutics as of Q4 2021.

Based on HHLR Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.